Focused ultrasound (FUS) is a minimally-invasive technology used for treatment of many
diseases, including diseases related to the colon, uterus, prostate, and brain. Although it has …

Alzheimer's disease (AD) is the most common cause of dementia in the elderly, with
tremendous impact on the affected individuals and the society. Definitive diagnosis can be …

Amyloid imaging represents a significant advance as an adjunct in the diagnosis of
Alzheimer's disease (AD) because it is the first imaging modality that identifies in vivo …

Abstract Fluselenamyl (5), a novel planar benzoselenazole shows traits desirable of
enabling noninvasive imaging of Aβ pathophysiology in vivo; labeling of both diffuse (an …

Background: Alzheimer's disease (AD) is the most common form of dementia. Neuroimaging
methods have widened the horizons for AD diagnosis and therapy. The goals of this work …

Radiopharmaceuticals are increasingly playing a leading role in diagnosing, monitoring,
and treating disease. In comparison with conventional pharmaceuticals, the development of …

To evaluate the efficacy of 18F-FC119S as a positron emission tomography (PET)
radiopharmaceutical for the imaging of Alzheimer's disease (AD), we studied the drug …

The pathological accumulation of different peptides is the common base of many
neurodegenerative processes, such as Alzheimer's disease (AD). AD is characterized by …

Für Morbus Alzheimer (M. Alzheimer), der weltweit über 60% der Demenzerkrankungen
ausmacht [3], gilt, dass sich die neuropathologischen Veränderungen im Gehirn der …

Positron emission tomography (PET) has become a widespread and indispensable tool for
non-invasive oncological, cardiological and neurological diagnosis. With its increase use …